alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 60, Number 92 (Friday, May 12, 1995)]
[Notices]
[Page 25757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-11708]



-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION
[File No. 1-6407]


Issuer Delisting; Notice of Application To Withdraw From Listing 
and Registration; (Southern Union Company, Common Stock, $1.00 Par 
Value)

May 5, 1995.
    The Southern Union Company (``Company'') has filed an application 
with the Securities and Exchange Commission (``Commission''), pursuant 
to Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and 
Rule 12d2-2(d) promulgated thereunder, to withdraw the above specified 
security (``Security'') from listing and registration on the American 
Stock Exchange, Inc. (``Amex'').
    The reasons alleged in the application for withdrawing the Security 
from listing and registration include the following:
    According to the Company, in addition to being listed on the Amex, 
the Security is listed on the New York Stock Exchange, Inc. (``NYSE''). 
The Security commenced trading on the NYSE at the opening of business 
on February 27, 1995, and concurrently therewith the Security was 
suspended from trading on the Amex.
    According to the Company, its Board of Directors determined that 
listing on the NYSE would benefit both the Company, its shareholders 
and its utility customers by broadening the potential investment 
audience and providing greater liquidity for the Security.
    In making the decision to withdraw the Security from listing on the 
Amex, the Company considered the direct and indirect costs and expenses 
attendant in maintaining the dual listing of the Security on the NYSE 
and on the Amex. The Company does not see any particular advantage in 
the dual trading of the Security and believes that dual listing would 
fragment the market.
    Any interested person may, on or before May 26, 1995, submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the 
application has been made in accordance with the rules of the exchanges 
and what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 95-11708 Filed 5-11-95; 8:45 am]
BILLING CODE 8010-01-M
<PAGE>


                                                                      EXHIBIT 32

           WINTHROP RESIDENTIAL ASSOCIATES III, A LIMITED PARTNERSHIP
                            FORM 10-QSB JUNE 30, 2003

                            CERTIFICATION PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Winthrop Residential
Associates III, A Limited Partnership, (the "Partnership"), on Form 10-QSB for
the quarterly period ended June 30, 2003, as filed with the Securities and
Exchange Commission on the date hereof (the "Report"), the undersigned, in the
capacities and on the date indicated below, hereby certifies pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that: (1) the Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities and Exchange Act of 1934; and (2) the
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Partnership.



Date:  August 19, 2003                               /s/ Michael L. Ashner
                                                     ---------------------------
                                                     Michael L. Ashner
                                                     Chief Executive Officer


Date:  August 19, 2003                               /s/ Thomas C. Staples
                                                     ---------------------------
                                                     Thomas C. Staples
                                                     Chief Financial Officer








                                    19 of 20
Exhibit 10.2
   RECITALS
   ARTICLE I  CREDIT TERMS
  Line of Credit
 Letter of Credit Subfeature




---



##### 



Borrowing and Repayment
  Standby Letter of Credit
 Repayment of Drafts
  Interest
 Computation and Payment
 Unused Commitment Fee
 Letter of Credit Fees
  -2-




---



##### 



ARTICLE II  REPRESENTATIONS AND WARRANTIES
        -3-




---



##### 



ARTICLE III  CONDITIONS
  Approval of Bank Counsel
  -4-




---



##### 



Documentation
 (i)
    
    This Agreement and each promissory note or other instrument or document
required hereby.
 (ii)
    
    Corporate Resolution: Borrowing.
 (iii)
    
    Certificate of Incumbency.
 (iv)
    
    Such other documents as Bank may require under any other Section of this
Agreement.
 Financial Condition
 Insurance
  Compliance
 Documentation
 ARTICLE IV  AFFIRMATIVE COVENANTS
     -5-




---



##### 



-6-




---



##### 



ARTICLE V  NEGATIVE COVENANTS
      -7-




---



##### 



provided
     -8-




---



##### 



provided
  provided
 provided
 provided
 ARTICLE VI  EVENTS OF DEFAULT
     -9-




---



##### 



-10-




---



##### 



ARTICLE VII  MISCELLANEOUS
   BORROWER:
    Dionex Corporation501 Mercury DriveSunnyvale, CA 94085BANK:
    WELLS FARGO BANK, NATIONAL ASSOCIATIONPeninsula RCBO400 Hamilton AvenuePalo Alto, CA 94301
   -11-




---



##### 



-12-




---



##### 



Arbitration
 Governing Rules
 No Waiver of Provisional Remedies, Self-Help and Foreclosure
 Arbitrator Qualifications and Powers
  -13-




---



##### 



Discovery
 Class Proceedings and Consolidations
 Payment Of Arbitration Costs And Fees .
 Real Property Collateral; Judicial Reference
 Miscellaneous
  -14-




---



##### 



Small Claims Court
  DIONEX CORPORATION
    
    WELLS FARGO BANK, NATIONAL ASSOCIATIONBy:

    /s/ [ILLEGIBLE]
    
    By:Title:


Exec.
V.P. & CFO
    
    
    
    Tahereh SadeghiAssistant Vice President
  -15-
PRO HAC VICE APPLICATION & ORDER October 2012

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

 

 Plaintiff(s), 

v.

 

 Defendant(s).

)

)

)

)

)

)

)

)

)

)

Case No: _______________

APPLICATION FOR

ADMISSION OF ATTORNEY

PRO HAC VICE

(CIVIL LOCAL RULE 11-3) 

I, , an active member in good standing of the bar of 

 , hereby respectfully apply for admission to practice pro hac vice in the 

Northern District of California representing: in the 

above-entitled action. My local co-counsel in this case is __________________________________, an 

attorney who is a member of the bar of this Court in good standing and who maintains an office 

within the State of California. 

MY ADDRESS OF RECORD: LOCAL CO-COUNSEL’S ADDRESS OF RECORD:

MY TELEPHONE # OF RECORD: LOCAL CO-COUNSEL’S TELEPHONE # OF RECORD:

MY EMAIL ADDRESS OF RECORD: LOCAL CO-COUNSEL’S EMAIL ADDRESS OF RECORD:

I am an active member in good standing of a United States Court or of the highest court of 

another State or the District of Columbia, as indicated above; my bar number is: . 

A true and correct copy of a certificate of good standing or equivalent official document from said 

bar is attached to this application.

I agree to familiarize myself with, and abide by, the Local Rules of this Court, especially the 

Standards of Professional Conduct for attorneys and the Alternative Dispute Resolution Local Rules. 

I declare under penalty of perjury that the foregoing is true and correct. 

Dated: 

APPLICANT

ORDER GRANTING APPLICATION

FOR ADMISSION OF ATTORNEY PRO HAC VICE

IT IS HEREBY ORDERED THAT the application of is granted, 

subject to the terms and conditions of Civil L.R. 11-3. All papers filed by the attorney must indicate 

appearance pro hac vice. Service of papers upon, and communication with, local co-counsel 

designated in the application will constitute notice to the party.

Dated: 

UNITED STATES DISTRICT/MAGISTRATE JUDGE

Reset Form Eddie Lindsey

4:17-cv-00753

United Air Lines, Inc., Continental Airl

Steven John Mitby Steven John Mitby Steven John Mitby Texas Supreme Court Eddie Lindsey Jason Skaggs

1221 McKinney, Ste. 2500 

Houston, TX 77010

530 Lytton Avenue, 2nd Floor 

Palo Alto, CA 94301 (713) 655-1101 (650) 617-3226 smitby@azalaw.com jason@skaggsfaucette.com 24037123 03/16/17 March 16, 2017.

Case 3:17-cv-00753-WHA Document 23 Filed 03/16/17 Page 1 of 1
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

Case No. 3:17-cv-00939-WHA

STIPULATION REGARDING INITIAL DISCLOSURES AND RULE 26(F) REPORT

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN FRANCISCO DIVISION

WAYMO LLC,

Plaintiff,

vs.

UBER TECHNOLOGIES, INC.; 

OTTOMOTTO LLC; OTTO TRUCKING 

LLC,

Defendants.

CASE NO. 3:17-cv-00939-WHA

STIPULATION REGARDING INITIAL 

DISCLOSURES AND RULE 26(f) 

REPORT

Case 3:17-cv-00939-WHA Document 137 Filed 04/03/17 Page 1 of 3
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

-2- Case No. 3:17-cv-00939-WHA

STIPULATION REGARDING INITIAL DISCLOSURES AND RULE 26(F) REPORT

WHEREAS, on March 20, 2017, Plaintiff Waymo LLC (“Waymo”) and Defendants Uber 

Technologies Inc., Ottomotto LLC, and Otto Trucking LLC (collectively, “Defendants”) held an 

initial conference pursuant to Fed. R. Civ. P. 26(f);

WHEREAS, the Court scheduled the Initial Case Management Conference for May 18, 2017, 

and ordered the parties to submit the Case Management Statement by May 11, 2017 (Dkt. No. 20);

WHEREAS, the Court ordered the parties to file a written joint plan for further expedited 

discovery before the hearing on Defendants’ motion to compel arbitration (Dkt. No. 61);

WHEREAS, the Court has set the hearing on Defendants’ motion to compel arbitration for 

April 27, 2017 (Dkt. No. 130);

WHEREAS, the parties wish to clarify the deadlines for serving initial disclosures under Rule 

26(a)(1) and for filing their Case Management Statement under Rule 26(f);

THEREFORE, the parties stipulate as follows:

1. In light of the fact that the parties held their Rule 26(f) conference on March 20, 2017, the 

parties will serve their initial disclosures under Rule 26(a)(1) on April 3, 2017;

2. In light of the Court’s previous Order that the parties file a written joint plan for further 

expedited discovery before April 27, 2017, the parties will submit their Case Management 

Statement -- together with that joint plan -- before April 27, 2017.

IT IS STIPULATED.

Case 3:17-cv-00939-WHA Document 137 Filed 04/03/17 Page 2 of 3
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

-3- Case No. 3:17-cv-00939-WHA

STIPULATION REGARDING INITIAL DISCLOSURES AND RULE 26(F) REPORT

DATED: April 3, 2017

/s/ Charles K. Verhoeven

Charles K. Verhoeven

QUINN EMANUEL URQUHART & 

SULLIVAN, LLP

Attorneys for WAYMO LLC

DATED: April 3, 2017

/s/ Arturo J. Gonzalez

Arturo J. Gonzalez

MORRISON & FOERSTER LLP

Attorneys for UBER TECHNOLOGIES INC., 

OTTOMOTTO LLC, AND OTTO TRUCKING 

LLC

PURSUANT TO STIPULATION, IT IS SO ORDERED.

DATED: ____________, 2017 ___________________________________

 The Honorable William H. Alsup

Case 3:17-cv-00939-WHA Document 137 Filed 04/03/17 Page 3 of 3
*ORDER E-FILED: 6/20/2007* AND ORDER

Case 5:05-cv-01962-HRL Document 97 Filed 06/20/07 Page 1 of 2
UNITED STATES

D

I

S

TRICT COU TR

ON RTHERN

DIST

RICT

OF CALIFORNIA

GRANTED

Judge

Howard

R. Lloyd

Case 5:05-cv-01962-HRL Document 97 Filed 06/20/07 Page 2 of 2
### Michigan Supreme Court Lansing, Michigan

Robert P. Young, Jr.,
Chief Justice

Michael F. Cavanag h Marilyn Kell y Stephen J. Markma n Diane M. Hathawa y Mary Beth Kell y Brian K. Zahra,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk June 28, 2011

t0620 

# Order

June 28, 2011

142130 & (17)

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 142130 COA: 297927 Wayne CC: 93-010422-FC KUSHAWN S. MILES, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the October 15, 2010 order of the Court of Appeals is considered , and it is DENIED, because the defendant has

failed to meet the burden of establishing entitlement to re lief under MCR 6.508(D). The motion to expand record is DENIED.
Elroy CHESTER, petitioner, v. Rick THALER, Director, Texas Department of Criminal Justice, Correctional Institutions Division.

No. 12-10730, 12A1192.

Supreme Court of the United States

June 12, 2013.

Application for stay of execution of sentence of death presented to Justice SCALIA and by him referred to the Court denied. Petition for writ of certiorari to *2824the United States Court of Appeals for the Fifth Circuit denied.
Terry E. SHOTTS, petitioner, v. ILLINOIS.

No. 12-9459.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the Appellate Court of Illinois, Fourth District, denied.
Melissa STRAWBRIDGE, petitioner, v. Elaine LORD.

No. 12-9130.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Second Circuit denied.
Andre WARE, petitioner, v. UNITED STATES.

No. 12-9085.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
FDA Public Workshop: Biomarker-driven drug development for allergic diseases and asthma

February 22, 2024

Session 1. Regulatory Approach to Biomarkers; 8:00 AM-11:15AM

Moderator: David Kaslow, MD FDA, CBER

 8:00 AM Welcome Peter Marks, MD, PhD FDA, CBER

 8:10 The FDA Biomarker Program Jeff Siegel, MD FDA, CDER

 8:30 The EU Biomarker Program Stefan Vieths, PhD Paul Erlich Institut, FRG

 8:50 Role of translational science in biomarker and 

drug development

Peter Stein, MD FDA, CDER

 9:10 Role of Omics in Biomarker Applications & 

Discovery

Richard Beger, PhD FDA, NCTR

 9:30 Extrapolation of a Biomarkers between age 

groups

Lynne Yao, MD FDA, CDER

 9:50 NIAID Support of Biomarker Research in Allergic 

Disease

Alkis Togias, MD NIH, NIAID

 10:10 Panel discussion/Q & A

 10:40 Break

 Session 2. Biomarkers in Respiratory Allergic Disease; 11:15 AM – 1:25 PM

Moderator: Gurjit Khurana Hershey, MD, PhD Cincinnati Children's Hospital

 11:00 Allergic rhinoconjunctivitis and asthma: current 

clinical endpoints for efficacy

Syed H. Arshad MBBS, DM, FRCP Southampton UK

 11:25 Biomarkers and asthma endotypes Sally Wenzel, MD University of Pittsburgh

 11:45 Component resolved testing and "IgE quality" as 

prognostic and predictive biomarkers

Robert Hamilton, PhD Johns Hopkins University

12:05 PM Break

 1:00 Host Prognostic Biomarkers for childhood 

asthma 

Matthew Altman, MD, Mphil Benaroya Research Institute

 1:20 Cellular biomarkers for response to AIT for 

respiratory allergies

Mohamed H. Shamji, PhD Imperial College

 1:40 Panel discussion/Q & A

 2:10 Break

Session 3: Biomarkers in Food Allergy; 2:30 PM to 5: 00 PM

Moderator: Alkis Togias, MD NIAID, NIH

 2:30 Food allergy: risk factors and current clinical 

endpoints for efficacy

Pamela Guerrerio, MD, PhD NIH, NIAID

 2:50 The relationship of atopic skin disease to food 

allergy

Olena Goleva, PhD National Jewish Health

 3:10 Basophil Activation Test: ready for primetime? Alexandra Santos, MD, MSc King's College

 3:30 Component resolved testing and "IgE quality" as 

prognostic and predictive biomarkers/"epitope"

Hugh Sampson, MD Icahn School of Medicine

 3:50 Host Prognostic Biomarkers for food allergy Erik Wambre, PhD, MSc Icahn School of Medicine

 4:10 Cellular biomarkers for response to AIT for food 

allergies

Wayne Shreffler, MD, PhD Massachusetts General Hospital

 4:30 Panel discussion/Q & A

 5:00 Adjourn
[Federal Register Volume 60, Number 81 (Thursday, April 27, 1995)]
[Unknown Section]
[Pages 20749-20750]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-10307]



=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Antitrust Division


Notice Pursuant to the National Cooperative Research and 
Production Act of 1993--Open Software Foundation, Inc.

    Notice is hereby given that, on January 26, 1995, pursuant to 
Section 6(a) of the National Cooperative Research and Production Act of 
1993, 15 U.S.C. 4301 et seq. (``the Act''), Open Software Foundation, 
Inc. has filed written notifications simultaneously with the Attorney 
General and the Federal Trade Commission disclosing changes in its 
membership. The [[Page 20750]] notifications were filed for the purpose 
of extending the Act's provisions limiting the recovery of antitrust 
plaintiffs to actual damages under specified circumstances. 
Specifically, the identities of the new, non-voting members of OSF are 
as follows: NTT Data Communications Systems Corporation, Tokyo, JAPAN; 
and Toshiba Corporation, Tokyo, JAPAN.
    No other changes have been made in either the membership or planned 
activity of the group research project. Membership in this group 
research project remains open, and OSF intends to file additional 
written notifications disclosing all changes in membership.
    On May 11, 1994, OSF filed its original notification pursuant to 
Section 6(a) of the Act. The Department of Justice published a notice 
in the Federal Register pursuant to Section 6(b) of the Act on August 
31, 1994 (59 FR 45009).
    The last notification was filed with the Department on November 7, 
1994. A notice was published in the Federal Register pursuant to 
Section 6(b) of the Act on February 16, 1995 (60 FR 9052).
Constance K. Robinson,
Director of Operations, Antitrust Division.
[FR Doc. 95-10307 Filed 4-26-95; 8:45 am]
BILLING CODE 4410-01-M
Kurt VAN BRYANT, Appellant, v. The STATE of Florida, Appellee.

No. 3D19-421

District Court of Appeal of Florida, Third District.

Opinion filed April 24, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      11,921,100
<SECURITIES>                                72,915,100
<RECEIVABLES>                                2,003,100
<ALLOWANCES>                                 1,800,000
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                       4,919,100
<DEPRECIATION>                                 266,400
<TOTAL-ASSETS>                             292,371,600
<CURRENT-LIABILITIES>                        2,378,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                    27,568,400
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>               292,371,600
<SALES>                                              0
<TOTAL-REVENUES>                            10,531,100
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             4,423,700
<LOSS-PROVISION>                             3,374,400
<INTEREST-EXPENSE>                           4,584,200
<INCOME-PRETAX>                              (809,600)
<INCOME-TAX>                                  (82,200)
<INCOME-CONTINUING>                          (727,400)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (727,400)
<EPS-BASIC>                                      (.55)
<EPS-DILUTED>                                    (.55)


</TABLE>
Federal Register / Vol. 60, No. 91 / Thursday, May 11, 1995 / Notices 25263

4. 75 hours

5. 10 minutes

6. On occasion

7. 450 respondents

[FR Doc. 95–11575 Filed 5–10–95; 8:45 am]

BILLING CODE 8320–01–M

Information Collection Under OMB

Review: Veterans Mortgage Life

Insurance Health Statement, VA Form

29–0562

AGENCY: Department of Veterans Affairs.

ACTION: Notice.

The Department of Veterans Affairs

has submitted to OMB the following

proposal for the collection of

information under the provisions of the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). This document lists the

following information: (1) The title of

the information collection, and the

Department form number(s), if

applicable; (2) a description of the need

and its use; (3) who will be required or

asked to respond; (4) an estimate of the

total annual reporting hours, and

recordkeeping burden, if applicable; (5)

the estimated average burden hours per

respondent; (6) the frequency of

response; and (7) an estimated number

of respondents.

ADDRESSES: Copies of the proposed

information collection and supporting

documents may be obtained from Trish

Fineran, Veterans Benefits

Administration (20M30), Department of

Veterans Affairs, 810 Vermont Avenue,

NW, Washington, DC 20420, (202) 273–

6886.

Comments and questions about the

items on the list should be directed to

VA’s OMB Desk Officer, Joseph Lackey,

NEOB, Room 3002, Washington, DC

20503, (202) 395–7316. Do not send

requests for benefits to this address.

DATES: Comments on the information

collection should be directed to the

OMB Desk Officer by no later than June

12, 1995.

Dated: May 4, 1995.

By direction of the Secretary.

Donald L. Neilson,

Director, Information Management Service.

Reinstatement

1. Veterans Mortgage Life Insurance

Health Statement, VA Form 29–

0562

2. This form is used by the Veterans

Benefits Administration (VBA) to

obtain health information when an

application for Veterans Mortgage

Life Insurance (VMLI) is received.

The information collected is used

by the insurance personnel to

determine if VMLI health

requirements are met

3. Individuals or households

4. 20 hours

5. 5 minutes

6. On occasion

7. 240 respondents

[FR Doc. 95–11576 Filed 5–10–95; 8:45 am]

BILLING CODE 8320–01–M
Alaa Mohammad ALI, petitioner, v. UNITED STATES.

No. 12-805.

Supreme Court of the United States

May 13, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Armed Forces denied.
我應好好待在家

起床後感到狀況很差,同時有腹瀉與 我很想躺回床上休息,但是堆積如山的帳 我還是強打起精神打卡上班,雖然我知道我看

生病的症狀。 單讓我不敢請假。 起來氣色很糟糕,我知道我不應該去上班的。

客戶點餐如排山倒海而來,所以我到達上班地 那時 Carlos 正與他的家人享受愉快的用餐時間, 食物上桌後,他拿起食物馬上就吃完

點後立刻準備製作漢堡。 這裡是他最喜歡的餐廳。 他的漢堡,他還吃了他姊姊的餐點。

當天晚上,Carlos 有兩次腹痛的症狀,病狀變 後來還有 33 人因為食用了我生病時所 我當初就應該做出正確決定,好好待在家中休息,就可

得越來越嚴重,最後送了急診室。 製作的食物而生病了,衛生局也因此勒 以避免這一切不幸事件發生。由於餐廳需關閉暫停營

令餐廳歇業。 業,我也失去收入來源,我真的感到相當慚愧。

為維護大眾健康,生病時請待在家中休息。